Sphaera Pharma
Navi Mumbai, India· Est.
India‑based biotech offering integrated, low‑cost drug discovery services and repurposing pipelines for rare and neglected diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India‑based biotech offering integrated, low‑cost drug discovery services and repurposing pipelines for rare and neglected diseases.
OncologyMetabolic DisordersCentral Nervous SystemMitochondrial DysfunctionRare Genetic Disorders
Technology Platform
Proprietary chemistry and AI‑driven platform for rapid hit‑to‑lead optimization, including heterocycle, steroid, and PROTAC libraries, coupled with end‑to‑end pre‑clinical pharmacology and ADME services.
Opportunities
Leverage low‑cost, integrated R&D services to capture Indian and emerging market demand for affordable therapies, especially in rare and neglected diseases.
Risk Factors
Dependence on external collaborations and funding to advance pre‑clinical assets; regulatory hurdles for repurposed drugs could delay clinical entry.
Competitive Landscape
Competes with Indian CROs and early‑stage biotech service firms such as Syngene, Wockhardt, and Intas; differentiates through its AI‑enhanced chemistry platform and focus on affordable therapeutics for underserved markets.